Literature DB >> 3839390

Prevention of intraocular pressure elevation following neodymium-YAG laser posterior capsulotomy.

C U Richter, G Arzeno, H R Pappas, C A Arrigg, P Wasson, R F Steinert.   

Abstract

Thirty-two eyes of 32 patients were treated with 0.5% timolol, 2% pilocarpine, or normal saline five and 30 minutes following neodymium-YAG laser posterior capsulotomy in a randomized, double-masked study. Mean maximum intraocular pressure (IOP) elevation was 8 +/- 2 mm Hg following treatment with normal saline, 5 +/- 3 mm Hg following treatment with 2% pilocarpine, and 1 +/- 2 mm Hg following treatment with 0.5% timolol. Fewer patients treated with 0.5% timolol developed an IOP elevation of 5 mm Hg or more than control patients. On aphakic patient treated with 0.5% timolol developed a maximum IOP greater than or equal to 40 mm Hg. We found that treatment with 0.5% timolol after neodymium-YAG laser posterior capsulotomy provides partial protection from IOP elevation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839390     DOI: 10.1001/archopht.1985.01050070038026

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy.

Authors:  Ji-Ping Cai; Jin-Wei Cheng; Rui-Li Wei; Xiao-Ye Ma; Feng Jiang; Huang Zhu; You Li
Journal:  Int Ophthalmol       Date:  2007-06-22       Impact factor: 2.031

2.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

3.  Neodymium: YAG laser iridotomies--short-term comparison with capsulotomies and long-term follow-up.

Authors:  C R Canning; M R Capon; E S Sherrard; M G Kerr Muir; R Pearson; R J Cooling
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

4.  Prevention of IOP-rise following Nd-YAG laser capsulotomy with pre-operative timolol eye-drops and 1 tablet acetazolamide 250 mg systematically.

Authors:  T N Boen-Tan; J S Stilma
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

5.  Prevention of IOP-rise following Nd-YAG laser capsulotomy with topical timolol and indomethacin.

Authors:  D Van der Feltz van der Sloot; J S Stilma; T N Boen-Tan; P D Bezemer
Journal:  Doc Ophthalmol       Date:  1988 Oct-Nov       Impact factor: 2.379

6.  Prophylactic use of acetazolamide to prevent intraocular pressure elevation following Nd-YAG laser posterior capsulotomy.

Authors:  I D Ladas; G P Pavlopoulos; S N Kokolakis; G P Theodossiadis
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

Review 7.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

8.  Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy.

Authors:  I P Pollack; R H Brown; A S Crandall; A L Robin; R H Stewart; G L White
Journal:  Trans Am Ophthalmol Soc       Date:  1988
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.